NCT03168568 Differential Vascular and Endocrine Effects of Valsartan/Sacubitril in Heart Failure With Reduced Ejection Fraction Status COMPLETED Phase PHASE4
NCT03167242 Efficacy and Safety of KAF156 in Combination With LUM-SDF in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria Status COMPLETED Phase PHASE2
NCT03158311 Study to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + Tiotropium Status COMPLETED Phase PHASE3
NCT03152591 Study of Pharmacodynamics of LIK066 in Overweight and Obese Women With Polycystic Ovary Syndrome Status COMPLETED Phase PHASE2
NCT03152552 A Dose Finding Study to Assess the Effect of LIK066 Compared to Placebo or Empagliflozin in Patients With Type 2 Diabetes Mellitus and Heart Failure Status TERMINATED Phase PHASE2
NCT03150160 Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma Status COMPLETED Phase PHASE4
NCT03141086 A Study to Assess the Wakefulness Promoting Effect, Safety, Tolerability, and Pharmacokinetics (PK) of LML134 in Shift Work Disorder Status TERMINATED Phase PHASE2
NCT03138811 A Bronchoprovocation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CSJ117 in Adult Subjects With Mild Atopic Asthma Status COMPLETED Phase PHASE1
NCT03137784 Bronchodilator Effects and Safety of Glycopyrronium Bromide (25 ug and 50 ug o.d.) in Asthma Status COMPLETED Phase PHASE2/PHASE3
NCT03136861 SKIPPAIN - Speed of Onset of SecuKinumab-Induced Relief From Pain in Patients With AxIal SpoNdyloarthritis Status COMPLETED Phase PHASE3
NCT03131479 Study of PK/PD, Safety and Tolerability of LIK066 in Patients With Decreased Renal Function. Status COMPLETED Phase PHASE2
NCT03131453 A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease Status TERMINATED Phase PHASE2/PHASE3
NCT03114319 Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT03114228 An Expanded Treatment Protocol (ETP) of Midostaurin (PKC412) in Patients 18 Years of Age or Older With Newly-diagnosed FLT3-mutated Acute Myeloid Leukemia (AML) Status NO_LONGER_AVAILABLE Phase N/A
NCT03111992 Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma Status COMPLETED Phase PHASE1
NCT03108027 Assess Bronchodilator Effect QVM149 Dosed Either in the Morning or Evening Compared to Placebo in Patients With Asthma Status COMPLETED Phase PHASE2
NCT03106779 Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs Status COMPLETED Phase PHASE3
NCT03105609 Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging Status TERMINATED Phase N/A